| 000 | 01076 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515065648.0 | ||
| 264 | 0 | _c20071030 | |
| 008 | 200710s 0 0 eng d | ||
| 022 | _a1750-2799 | ||
| 024 | 7 |
_a10.1038/nprot.2006.322 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOlafsen, Tove | |
| 245 | 0 | 0 |
_aTunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragment. _h[electronic resource] |
| 260 |
_bNature protocols _c2006 |
||
| 300 |
_a2048-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies _xgenetics |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 |
_aIsotope Labeling _xmethods |
| 650 | 0 | 4 |
_aMutagenesis, Site-Directed _xmethods |
| 650 | 0 | 4 |
_aReceptors, Fc _xmetabolism |
| 650 | 0 | 4 |
_aRecombinant Proteins _xisolation & purification |
| 700 | 1 | _aKenanova, Vania E | |
| 700 | 1 | _aWu, Anna M | |
| 773 | 0 |
_tNature protocols _gvol. 1 _gno. 4 _gp. 2048-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nprot.2006.322 _zAvailable from publisher's website |
| 999 |
_c17033292 _d17033292 |
||